Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis

Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis

(2010) Daichi Inoue et al.   CLINICAL RHEUMATOLOGY

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis

(2010) Tadashi Nakamura et al.   CLINICAL RHEUMATOLOGY

More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases

(2010) M Vasala et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

(2009) S Nishida et al.   ANNALS OF THE RHEUMATIC DISEASES

Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview

(2009) Laura Obici et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis

(2009) Hiroe Sato et al.   CLINICAL RHEUMATOLOGY

Effective Anti-TNF-  Therapy Can Induce Rapid Resolution and Sustained Decrease of Gastroduodenal Mucosal Amyloid Deposits in Reactive Amyloidosis Associated with Rheumatoid Arthritis

(2009) T. KURODA et al.   JOURNAL OF RHEUMATOLOGY

A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

(2008) Takeshi Kuroda et al.   RHEUMATOLOGY INTERNATIONAL